PATH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
UiPath Inc (PATH) does not currently present a strong buy opportunity for a beginner investor with a long-term strategy. The technical indicators are bearish, analyst sentiment is mixed to neutral with lowered price targets, and there are no significant trading trends or proprietary trading signals to support a buy decision. While the company has launched new AI-driven products, the lack of consistent financial growth and modest ARR flow-through make it prudent to hold off on investing at this time.
The MACD is negatively expanding (-0.148), indicating bearish momentum. RSI is neutral at 30.027, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 10.05 and resistance at 10.837. The stock trend analysis suggests a 70% chance of further declines (-1.32% in the next day, -0.67% in the next week, -16.3% in the next month).
UiPath launched AI-Native Case Management capability, Maestro Case, which could enhance operational efficiency and attract enterprise clients. Analysts suggest the stock is undervalued with potential for long-term growth.
Analysts have lowered price targets recently, citing modest ARR growth and the need for consistent performance. Technical indicators are bearish, and there is no significant hedge fund or insider trading activity. Proprietary trading signals (AI Stock Picker and SwingMax) do not indicate a buy opportunity.
Financial data is unavailable for analysis, but analysts note modest ARR flow-through and the need for consistent growth in non-seed-based pricing.
Analyst sentiment is mixed to neutral. Recent price target changes include BMO Capital lowering the target to $13, Morgan Stanley reducing it to $15, and RBC Capital lowering it to $12. While some analysts acknowledge solid Q1 results and raised guidance, concerns over ARR growth and consistency persist.
